About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Weight of Cardiovascular Disease | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06053645

The Weight of Cardiovascular Disease

The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascu...

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Preventive/Vascular Research Team

CONTACT

(507) 538-7425 [email protected]

Kyla Lara-Breitinger, M.D.

CONTACT

(507) 284-4441 [email protected]

Sponsors

Lead Sponsor

Mayo Clinic

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•BMI ≥30 kg/m2
•At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
•Patients evaluated in the Cardiometabolic clinic
•Willingness to complete questionnaires/surveys
•Ability to complete monthly self-assessments at home

Exclusion Criteria

•BMI \<30 kg/m2
•Pregnancy or lactating women
•Hemodynamically unstable CVD
•Active malignancy
•Autoimmune or systemic inflammatory diseases
•Severe renal or hepatic failure
•Being considered unsafe to participate as determined by the study physician
•Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician
•Patients with active psychosis, mania, or substance use disorders

Related studies

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NCT05545306 · Obesity, Normal Physiology, and more

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

NCT04453072 · Obesity, Malignant Neoplasm

Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?

NCT07565051 · Morbid Obesity Requiring Bariatric Surgery

Pregnancy Exercise Mode Effect on Childhood Obesity

NCT04805502 · Pregnancy, Overweight and Obesity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 20, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment60

Start dateApr 2024

Last updatedOct 20, 2025

Condition

Cardiovascular Diseases Obesity

Locations shown

Mayo Clinic in Rochester

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions